Tablets are indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. Tablets is 25 mg once daily after a meal. The safety of chronic dosing in patients with moderate or severe hepatic or renal impairment has not been studied.
Tablets are round, biconvex, and off-white to slightly gray.
Each tablet contains 25 mg of exemestane. The tablets are printed on one side with the number 7663 in black.